FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Aarti Drugs Buyback 2024 and Jai Corp Buyback 2024.
Aarti Drugs Buyback 2024 is a Tender Offer buyback proposed to list at BSE, NSE while Jai Corp Buyback 2024 is a Tender Offer proposed to list at BSE, NSE.
Aarti Drugs Ltd. | Jai Corp Ltd. | |
---|---|---|
Logo | ![]() |
![]() |
Type of Buyback | Tender Offer | Tender Offer |
Listing At | BSE, NSE | BSE, NSE |
Face Value | ₹10 per share | |
Buyback Price | ₹900 per share | |
Issue Size | 6,65,000 shares | |
Issue Size (Amount) | ₹59.85 Crores | |
Buyback Ratio | ||
Registrar | Link Intime India Private Ltd | |
Lead Managers | Inga Ventures Pvt Ltd | |
Necessity of the buyback | The Company is proposing the Buyback to service the equity more efficiently. Additionally, the Company's management strives to increase equity shareholders value and the Buyback would result in, amongst other things: |
Aarti Drugs Buyback 2024 and Jai Corp Buyback 2024 buyback timetable. The investors should have the company's shares in their demat accounts as of the record date. Aarti Drugs Buyback 2024 Buyback record date is Sep 05, 2024. Jai Corp Buyback 2024 Buyback record date is Sep 10, 2024.
Aarti Drugs Ltd. | Jai Corp Ltd. | |
---|---|---|
Record Date | Sep 05, 2024 | Sep 10, 2024 |
Offer Open Date | ||
Offer Closure Date | ||
Last date for receipt of tender forms | ||
Finalisation of buyback | ||
Last Date for settlment of bids | ||
Last Date for extinguishment of shares |
Comparison of Aarti Drugs Buyback 2024 and Jai Corp Buyback 2024 financial data. The table below also includes a list of all relevant information like Stock Market Data, Compay Information, Lead Manager and Registrar.
Aarti Drugs Ltd. | Jai Corp Ltd. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial | Aarti Drugs Ltd. Financial Information (Restated Consolidated)
|
Jai Corp Ltd. Financial Information (Restated Consolidated)Jai Corp Ltd.'s revenue decreased by -19% and profit after tax (PAT) rose by 488% between the financial year ending with March 31, 2024 and March 31, 2023.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock price at BSE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock price at NSE |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|